I am a
Home I AM A Search Login

Papers of the Week


2020 Apr 08


Trans R Soc Trop Med Hyg


114


4

Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection.

Authors

Cordie A, Elsharkawy A, Abdel Alem S, Meshaal S, El Akel W, Abdellatif Z, Kamal W, Al Askalany M, Kamel S, Abdel Aziz H, Kandeel A, Esmat G
Trans R Soc Trop Med Hyg. 2020 Apr 08; 114(4):232-240.
PMID: 31925434.

Abstract

Novel direct-acting antiviral agents have shown great efficacy and tolerability in HCV-monoinfected patients. However, data are lacking regarding their efficacy and safety in HIV/HCV-genotype (GT) 4-coinfected patients.